These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29380060)

  • 1. Serum levels of a cell death biomarker predict the development of cirrhosis-related conditions in primary biliary cholangitis.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Nozawa Y; Ohira H
    Med Mol Morphol; 2018 Sep; 51(3):176-185. PubMed ID: 29380060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
    Sekiguchi T; Umemura T; Fujimori N; Shibata S; Ichikawa Y; Kimura T; Joshita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
    PLoS One; 2015; 10(6):e0131658. PubMed ID: 26110613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients.
    Namisaki T; Moriya K; Kitade M; Kawaratani H; Takeda K; Okura Y; Takaya H; Nishimura N; Seki K; Kaji K; Sato S; Sawada Y; Yamao J; Mitoro A; Uejima M; Mashitani T; Shimozato N; Nakanishi K; Furukawa M; Saikawa S; Kubo T; Yoshiji H
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):23-30. PubMed ID: 27755231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Curr Gastroenterol Rep; 2010 Feb; 12(1):13-22. PubMed ID: 20425480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
    Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.
    Neuman M; Angulo P; Malkiewicz I; Jorgensen R; Shear N; Dickson ER; Haber J; Katz G; Lindor K
    J Gastroenterol Hepatol; 2002 Feb; 17(2):196-202. PubMed ID: 11966951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis.
    Takemoto R; Miyake Y; Harada K; Nakanuma Y; Moriya A; Ando M; Hirohata M; Yamamoto K
    Intern Med; 2014; 53(13):1429-33. PubMed ID: 24990335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.
    Oweira H; Sadeghi M; Volker D; Mieth M; Zidan A; Khajeh E; Ghamarnejad O; Fonouni H; Weiss KH; Schmidt J; Lahdou I; Mehrabi A
    Ann Transplant; 2018 Jun; 23():393-400. PubMed ID: 29880786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of serum fractalkine in primary biliary cirrhosis.
    Harada K; Kakuda Y; Nakamura M; Shimoda S; Nakanuma Y
    Dig Dis Sci; 2013 Oct; 58(10):3037-43. PubMed ID: 23765258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Holtmeier J; Leuschner U
    Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
    Umemura T; Sekiguchi T; Joshita S; Yamazaki T; Fujimori N; Shibata S; Ichikawa Y; Komatsu M; Matsumoto A; Shums Z; Norman GL; Tanaka E; Ota M
    Liver Int; 2017 Jun; 37(6):897-905. PubMed ID: 27860118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
    Corpechot C; Chazouilleres O
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.
    Waidmann O; Brunner F; Herrmann E; Zeuzem S; Piiper A; Kronenberger B
    Liver Int; 2016 Oct; 36(10):1464-72. PubMed ID: 26991828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
    Corpechot C; Chazouillères O; Poupon R
    J Hepatol; 2011 Dec; 55(6):1361-7. PubMed ID: 21703194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How the concept of biochemical response influenced the management of primary biliary cholangitis over time.
    Lammers WJ; Leeman M; Ponsioen CI; Boonstra K; van Erpecum KJ; Wolfhagen FH; Kuyvenhoven JP; Vrolijk JM; Drenth JP; Witteman EM; van Nieuwkerk CM; van der Spek BW; Witteman BJ; Erkelens GW; Verhagen MA; van Tuyl SA; Poen AC; Brouwer JT; Ter Borg F; Koek GH; van Ditzhuijsen TJ; Hansen BE;
    Neth J Med; 2016 Jul; 74(6):240-6. PubMed ID: 27571721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.